<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_kidney" accession="ERX682264" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682264</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_kidney</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_kidney</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_kidney" accession="ERS643859" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643859</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216853</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_kidney</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_kidney</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>kidney</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_liver" accession="ERX682265" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682265</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_liver</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_liver</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_liver" accession="ERS643860" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643860</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216854</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_liver</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_liver</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>liver</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_brain" accession="ERX682258" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682258</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_brain</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_brain</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_brain" accession="ERS643853" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643853</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216847</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_brain</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_brain</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>brain</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_spleen" accession="ERX682259" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682259</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_spleen</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_spleen</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_spleen" accession="ERS643854" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643854</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216848</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_spleen</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_spleen</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>spleen</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_testis" accession="ERX682260" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682260</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_testis</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_testis</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_testis" accession="ERS643855" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643855</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216849</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_testis</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_testis</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>testis</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_heart" accession="ERX682261" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682261</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_heart</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_heart</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_heart" accession="ERS643856" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643856</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216850</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_heart</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_heart</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>heart</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_lung" accession="ERX682262" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682262</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_lung</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_lung</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_lung" accession="ERS643857" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643857</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216851</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_lung</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_lung</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>lung</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
  <EXPERIMENT alias="E-MTAB-3261:PolyA+_muscle" accession="ERX682263" center_name="WELLCOME TRUST SANGER INSTITUTE" broker_name="ArrayExpress">
    <IDENTIFIERS>
      <PRIMARY_ID>ERX682263</PRIMARY_ID>
      <SUBMITTER_ID namespace="WELLCOME TRUST SANGER INSTITUTE">E-MTAB-3261:PolyA+_muscle</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_muscle</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>Illumina HiSeq 2000 sequencing; GENCODE PCR-Seq Batch M1</TITLE>
    <STUDY_REF refname="E-MTAB-3261" refcenter="Wellcome Trust Sanger Institute" accession="ERP009351">
      <IDENTIFIERS>
        <PRIMARY_ID>ERP009351</PRIMARY_ID>
        <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>GENCODE PCR-Seq Batch M1</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR refname="E-MTAB-3261:PolyA+_muscle" accession="ERS643858" refcenter="Wellcome Trust Sanger Institute">
        <IDENTIFIERS>
          <PRIMARY_ID>ERS643858</PRIMARY_ID>
          <EXTERNAL_ID namespace="BioSample">SAMEA3216852</EXTERNAL_ID>
          <SUBMITTER_ID namespace="Wellcome Trust Sanger Institute">E-MTAB-3261:PolyA+_muscle</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>PolyA+_muscle</LIBRARY_NAME>
        <LIBRARY_STRATEGY>AMPLICON</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>RT-PCR</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <SINGLE/>
        </LIBRARY_LAYOUT>
        <LIBRARY_CONSTRUCTION_PROTOCOL>An 8-week-old C57/BL6 mouse purchased from Charles River was sacrificed, from which brain, heart, kidney, liver, lung, muscle (biceps femoris), spleen and testis were dissected. The tissues were homogenised in Trizol and total RNA was extracted. Any remaining DNA was removed with the Qiagen RNase-free DNase kit (ref. 79254) and total RNA was cleaned up with a Qiagen RNeasy mini kit (ref. 74104) column. Then, poly-A+ RNA  was extracted from the total RNA using the Qiagen Oligotex mRNA mini kit (ref. 70022). Reverse transcription was performed with the Invitrogen SuperScript III first-strand synthesis kit (ref. 18080-051) using random hexamers for priming. PCR amplifications were performed using 0.2 ng of initial poly A+ RNA  (as measured before doing the reverse transcription) in a  final volume of 12.5 uL with JumpStart REDTaq ReadyMix (Sigma-Aldrich) and a  primer concentration of 0.4 uM. Reactions took place in 384-well plates format on an automatized  Evoware platform (TECAN) combined with a Tetrad2 thermocycler (Bio-Rad) that  allows processing four plates in parallel. Because monoexonic amplification is  sensitive to genomic DNA contaminations, monoexonic models were assessed by  amplification of cDNA in which a dNTP analog was incorporated using the mRNA  Selective PCR Kit (TAKARA).</LIBRARY_CONSTRUCTION_PROTOCOL>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina HiSeq 2000</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
    <EXPERIMENT_ATTRIBUTES>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>Experimental Factor: organism part</TAG>
        <VALUE>skeletal muscle</VALUE>
      </EXPERIMENT_ATTRIBUTE>
      <EXPERIMENT_ATTRIBUTE>
        <TAG>LIBRARY_STRAND</TAG>
        <VALUE>not applicable</VALUE>
      </EXPERIMENT_ATTRIBUTE>
    </EXPERIMENT_ATTRIBUTES>
  </EXPERIMENT>
</EXPERIMENT_SET>
